Journal of Shandong University (Health Sciences) ›› 2020, Vol. 58 ›› Issue (12): 8-14.doi: 10.6040/j.issn.1671-7554.0.2020.0831
Previous Articles Next Articles
ZHANG Xiaolu, WANG Lili, CHEN Kaiming, LOU Xianzhi, ZHANG Man
CLC Number:
[1] 王新, 李春阳, 苏立平, 等. 动脉粥样硬化发病机制及治疗的研究进展[J]. 实用心脑肺血管病杂志, 2017, 25(2): 1-4. WANG Xin, LI Chunyang, SU Liping, et al. Progress on pathogenesis and treatment of atherosclerosis[J]. Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease, 2017, 25(2): 1-4. [2] Torres Nimbe, Guevara-Cruz Martha, Velázquez-Villegas Laura A, et al. Nutrition and Atherosclerosis[J]. Arch Med Res, 2015, 46(5): 408-426. [3] Kataoka Masaharu, Wang DZ. Non-coding RNAs including miRNAs and lncRNAs in cardiovascular biology and disease[J]. Cells, 2014, 3(3): 883-898. [4] Jiang WL, Agrawal D, Boosani C. Cell-specific histone modifications in atherosclerosis(Review)[J]. Mol Med Report, 2018, 18: 1215-1224. doi:10.3892/mmr.2018.9142. [5] Huang H, Lin S, Garcia BA, et al. Quantitative proteomic analysis of histone modifications[J]. Chem Rev, 2015, 115(6): 2376-2418. [6] 李双月, 刘淇麒, 冯馨锐, 等. 组蛋白去乙酰化酶3与血管内皮细胞的关系[J]. 吉林医药学院学报, 2018, 39(3): 201-203. LI Shuangyue, LIU Qiqi, FENG Xinrui. et al. Relationship of histone deacetylases 3 and vascular endothelial cells[J]. Journal of Jilin Medical University, 2018, 39(3): 201-203. [7] 钟磊,师健友,白兰. 组蛋白去乙酰化酶抑制剂JNJ-26481585抗食管癌活性及其作用机制研究[J]. 中国药理学通报, 2019, 35(4): 561-565. ZHONG Lei, SHI Jianyou, BAI Lan. Anti-esophageal cancer activity of JNJ-26481585 and its molecular mechanism[J]. Chinese Pharmacological Bulletin, 2019,35(4): 561-565. [8] 刘颖, 刘艳秋, 李翠玲, 等. 抑制NLRP3炎症小体中Caspase-1活化对大鼠颈动脉球囊损伤后内膜增生的保护作用[J]. 中山大学学报(医学科学版), 2017, 38(2): 250-253. LIU Ying, LIU Yanqiu, LI Cuiling, et al. Protective effects of inhibiting caspase-1 activation in NLRP3 inflammasome against intimal hyperplasia after balloon injury of carotid artery in rats[J]. Journal of Sun Yat-Sen University(Medical Sciences), 2017, 38(2): 250-253. [9] 郝阳, 郭晓辰, 张军平. 氧化应激和自噬在动脉粥样硬化中的作用研究新进展[J]. 中国动脉硬化杂志, 2017, 25(4): 404-410. HAO Yang, GUO Xiaochen, ZHANG Junping. The new progress of the role of oxidative stress and autophagy in atherosclerosis[J]. Chinese Journal of Arteriosclerosis, 2017, 25(4): 404-410. [10] 翁嘉懿, 严金川, 陈瑶, 等. CD137-CD137L信号通路通过活化T细胞核因子c1促进小鼠动脉粥样硬化斑块内血管新生[J]. 中华心血管病杂志, 2016, 44(12): 1040-1046. WENG Jiayi, YAN Jinchuan, CHEN Yao, et al. CD137-CD137L signaling promotes angiogenesis in atherosclerosis plaque of mice through activating nuclear factor of activated T cells c1[J]. Chinese Journal of Cardiology, 2016, 44(12): 1040-1046. [11] 李亚, 李曙, 马于林, 等. 单核细胞/高密度脂蛋白胆固醇比值与冠心病关系的探讨[J]. 中国心血管病研究, 2019, 17(12): 1110-1114. LI Ya, LI Shu, MA Yulin, et al. Association between monocyte to high-density lipoprotein cholesterol ratio and coronary artery disease[J]. Chinese Journal of Cardiovascular Research, 2019, 17(12): 1110-1114. [12] 查晴, 曹丽娟, 王燕萍, 等. oxLDL通过TLR4诱导脂质累积和炎症反应促进动脉粥样硬化的分子机制[J]. 上海交通大学学报(医学版), 2017, 37(5): 611-615. ZHA Qing, CAO Lijuan, WANG Yanping, et al. Molecular mechanism of oxLDL inducing lipid accumulation and inflammation in macrophages to promot atherosclerosis via TLR4 signaling pathway[J]. Journal of Shanghai Jiao Tong University(Medical Science), 2017, 37(5): 611-615. [13] 李闪, 田建伟, 梁立军, 等. 高脂高糖饮食对自发性高血压大鼠水通道蛋白1mRNA表达及对尿钠排泄的影响[J]. 中华老年心脑血管病杂志, 2014, 16(11): 1189-1191. LI Shan, TIAN Jianwei, LIANG Lijun, et al. Effect of high fat and glucose diet on expression of aquaporin-1 mRNA and excretion of urine natrium in spontaneous hypertensive rats[J]. Chinese Journal of Geriatric Heart Brain and Vessel Diseases, 2014, 16(11): 1189-1191. [14] Fuchs Y, Steller H. Live to Die another way: modes of programmed cell death and the signals emanating from dying cells[J]. Nat Rev Mol Cell Biol, 2015, 16(6): 329-344. [15] Zhang Y, Qin W, Zhang LY, et al. MicroRNA-26a prevents endothelial cell apoptosis by directly targeting TRPC6 in the setting of atherosclerosis[J]. Sci Rep, 2015, 24(5): 9401. [16] 刘俊田. 动脉粥样硬化发病的炎症机制的研究进展[J]. 西安交通大学学报(医学版), 2015, 36(2): 141-152. LIU Juntian. Progress in inflammatory pathogenesis of atherosclerosis[J]. Journal of Xian Jiaotong University(Medical Sciences), 2015, 36(2): 141-152. [17] Waldmann T, Schneider R. Targeting histone modifications-epigenetics in cancer[J]. Curr Opin Cell Biol, 2013, 25(2): 184-189. [18] Pang MY, Zhuang SG. Histone deacetylase: a potential therapeutic target for fibrotic disorders[J]. J Pharmacol Exp Ther, 2010, 335(2): 266-272. [19] Blakeslee WW, Wysoczynski CL, Fritz KS, et al. Class I HDAC inhibition stimulates cardiac protein SUMOylation through a post-translational mechanism[J]. Cell Signal, 2014, 26(12): 2912-2920. [20] Li Z, Martin M, Zhang J, et al. Krüppel-like factor 4 regulation of cholesterol-25-hydroxylase and liver X receptor mitigates atherosclerosis susceptibility[J]. Circulation, 2017, 136(14): 1315-1330. [21] 王深明, 吴伟滨. 重视动脉粥样硬化相关发病机制的研究[J]. 中华血管外科杂志, 2017, 2(4): 197-200. WANG Shenming, WU Weibin. Pay attention to the research on the pathogenesis of atherosclerosis[J]. Chinese Journal of Vascular Surgery, 2017, 2(4): 197-200. [22] Zawadzka M, Jagodziński PP. Exercise-induced epigenetic regulations in inflammatory related cells[J]. J Appl Biomed, 2017, 15(1): 63-70. [23] Rothbart SB, Strahl BD. Interpreting the language of histone and DNA modifications[J]. Biochim Biophys Acta, 2014, 1839(8): 627-643. [24] Hyun K, Jeon J, Park K, et al. Writing, erasing and reading histone lysine methylations[J]. Exp Mol Med, 2017, 49(4): e324. [25] 王维, 孟智启, 石放雄. 组蛋白修饰及其生物学效应[J]. 遗传, 2012, 34(7): 19-27. WANG Wei, MENG Zhiqi, SHI Fangxiong. Modification and biological role of histone[J]. Hereditas, 2012, 34(7): 19-27. [26] 宋博研, 朱卫国. 组蛋白甲基化修饰效应分子的研究进展[J]. 遗传, 2011, 33(4): 285-292. SONG Boyan, ZHU Weiguo. Advances in effector protein of histone methylation[J]. Hereditas, 2011, 33(4): 285-292. [27] 郭晓强. 组蛋白修饰研究的历程和意义[J]. 科学(上海), 2017, 69(2): 37-41. GUO Xiaoqiang. The history and significance of histone modification[J]. Science, 2017, 69(2): 37-41. [28] 余益本, 王建平. TLR信号通路研究进展[J]. 细胞与分子免疫学杂志, 2012, 28(12): 1331-1334. YU Yiben, WANG Jianping. Research progress of TLR signal pathway[J]. Chinese Journal of Cellular and Molecular Immunology, 2012, 28(12): 1331-1334. [29] Guo JX, Liang WQ, Li JH, et al. Knockdown of FSTL1 inhibits oxLDL-induced inflammation responses through the TLR4/MyD88/NF-κB and MAPK pathway[J]. Biochem Biophys Res Commun, 2016, 478(4): 1528-1533. [30] Ovsepyan VA, Gabdulkhakova AKh, Shubenkiva A, et al. Role of interleukin-10 gene promoter region polymorphism in the development of chronic lymphoid leukemia[J]. Bull Exp Biol Med, 2015, 160(2): 275-277. |
[1] | ZHANG Wei, ZHOU Yong, NIU Junjie, XU Ying, HOU Huaying, JIANG Yuhua. Radioprotective effects of valproic acid on normal brain tissues of rats [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(10): 11-15. |
[2] | NIU Jun-jie1, WANG Han1,2, XU Ying1, ZHOU Yong1, JIANG Yu-hua1. Valproate acid sodium enhancing radiation sensitivity of rat C6 glioma cells in vitro [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(06): 15-19. |
[3] | XU Nuo, JIANG Junmei, FENG Shanshan, WANG Guanhua, MENG Mei, YIN Xiaoyan. Effect of endogenous NO on expression of HDAC4 in a hepatocellular carcinoma model of nude mice [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(8): 48-51. |
[4] | WANG Guan-hua1, JIANG Jun-mei1, MENG Mei2, XU Nuo1. Effects of histone deacetylase 4 and vascular endothelial growth factor receptor-1 on invasion and adhesion in the human cancer cell line HepG2 in vitro [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(3): 68-72. |
[5] | WANG Guan-hua1, JIANG Jun-mei1, MENG Mei2, XU Nuo1. Effects of histone deacetylase 4 and vascular endothelial growth factor receptor-1 on invasion and adhesion in the human cancer cell line HepG2 in vitro [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(3): 68-72. |
[6] | . Effects of trichostatin A effects on natural killer cell survival and activity [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2009, 47(8): 50-54. |
|